Literature DB >> 25400428

Alpha-2-macroglobulin as a radioprotective agent: a review.

Xueying Chen1, Xiangbo Kong1, Zhaoqiang Zhang1, Wei Chen1, Jieyu Chen1, Huanyang Li1, Wanting Cao1, Yaping Ge1, Silian Fang1.   

Abstract

Radiation is an important modality in cancer treatment, and eighty percent of cancer patients need radiotherapy at some point during their clinical management. However, radiation-induced damage to normal tissues restricts the therapeutic doses of radiation that can be delivered to tumours and thereby limits the effectiveness of the treatment. The use of radioprotectors represents an obvious strategy to obtain better tumour control using a higher dose in radiotherapy. However, most of the synthetic radioprotective compounds studied have shown inadequate clinical efficacy owing to their inherent toxicity and high cost. Hence, the development of radioprotective agents with lower toxicity and an extended window of protection has attracted a great deal of attention, and the identification of alternative agents that are less toxic and highly effective is an absolute necessity. Recent studies have shown that alpha-2-macroglobulin (α2M) possesses radioprotective effects. α2M is a tetrameric, disulfide-rich plasma glycoprotein that functions as a non-selective inhibitor of different types of non-specific proteases and as a carrier of cytokines, growth factors, and hormones. α2M induces protein factors whose interplay underlies radioprotection, which supports the idea that α2M is the central effector of natural radioprotection in the rat. Pretreatment with α2M has also induced a significant reduction of irradiation-induced DNA damage and the complete restoration of liver and body weight. Mihailović et al. concluded that the radioprotection provided by α2M was in part mediated through cytoprotection of new blood cells produced in the bone marrow; these authors also indicated that an important aspect of the radioprotective effect of amifostine was the result of the induction of the endogenous cytoprotective capability of α2M. The radioprotective effects of α2M are possibly due to antioxidant, anti-fibrosis, and anti-inflammatory functions, as well as the maintenance of homeostasis, and enhancement of the DNA repair and cell recovery processes. This review is the first to summarise the observations and elucidate the possible mechanisms responsible for the beneficial effects of α2M. The lacunae in the existing knowledge and directions for future research are also addressed.

Entities:  

Keywords:  Alpha-2-macroglobulin (α2M); ionising radiation; mechanism; radiation-induced fibrosis; radioprotection

Year:  2014        PMID: 25400428      PMCID: PMC4220256          DOI: 10.3978/j.issn.1000-9604.2014.09.04

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  68 in total

Review 1.  Myofibroblasts. I. Paracrine cells important in health and disease.

Authors:  D W Powell; R C Mifflin; J D Valentich; S E Crowe; J I Saada; A B West
Journal:  Am J Physiol       Date:  1999-07

2.  The myofibroblast markers α-SM actin and β-actin are differentially expressed in 2 and 3-D culture models of fibrotic and normal skin.

Authors:  M C Vozenin; J L Lefaix; R Ridi; D S Biard; F Daburon; M Martin
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058

Review 3.  Alpha 2-macroglobulin. A multifunctional binding and targeting protein with possible roles in immunity and autoimmunity.

Authors:  W Borth
Journal:  Ann N Y Acad Sci       Date:  1994-09-10       Impact factor: 5.691

4.  Bacq and Alexander Award lecture--chemical radioprotection: past, present, and future prospects.

Authors:  J R Maisin
Journal:  Int J Radiat Biol       Date:  1998-04       Impact factor: 2.694

5.  Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy.

Authors:  David R Cassatt; Christine A Fazenbaker; Christine M Bachy; Mark S Hanson
Journal:  Semin Radiat Oncol       Date:  2002-01       Impact factor: 5.934

6.  Transforming growth factor-beta stimulates the expression of alpha 2-macroglobulin by cultured bovine adrenocortical cells.

Authors:  D L Shi; C Savona; J Gagnon; C Cochet; E M Chambaz; J J Feige
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

7.  [The pathogenesis of osteoradionecrosis].

Authors:  R Dambrain
Journal:  Rev Stomatol Chir Maxillofac       Date:  1993

8.  Tamoxifen enhancement of TNF-alpha induced MnSOD expression: modulation of NF-kappaB dimerization.

Authors:  Chotiros Daosukho; Kelley Kiningham; Edward J Kasarskis; Wanida Ittarat; Daret K St Clair
Journal:  Oncogene       Date:  2002-05-16       Impact factor: 9.867

9.  Serum alpha globulin fraction: survival-and-recovery effect in irradiated mice.

Authors:  M G Hanna; P Nettesheim; W D Fisher; L C Peters; M W Francis
Journal:  Science       Date:  1967-09-22       Impact factor: 47.728

10.  Structure of the human alpha-2 macroglobulin gene and its promotor.

Authors:  G Matthijs; K Devriendt; J J Cassiman; H Van den Berghe; P Marynen
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

View more
  5 in total

1.  Effect of Liposome-Encapsulated Dextrazide on Local Regulation of Extracellular Matrix Metabolism in Liver and Lungs of Mice with during Chronic BCG-Induced Granulomatosis.

Authors:  L B Kim; A N Putyatina; G S Russkikh; V A Shkurupy
Journal:  Bull Exp Biol Med       Date:  2021-03-31       Impact factor: 0.804

2.  The use of lumbar epidural injection of platelet lysate for treatment of radicular pain.

Authors:  Christopher Centeno; Jason Markle; Ehren Dodson; Ian Stemper; Matthew Hyzy; Christopher Williams; Michael Freeman
Journal:  J Exp Orthop       Date:  2017-11-25

3.  Clear differences in cerebrospinal fluid proteome between women with chronic widespread pain and healthy women - a multivariate explorative cross-sectional study.

Authors:  Patrik Olausson; Bijar Ghafouri; Emmanuel Bäckryd; Björn Gerdle
Journal:  J Pain Res       Date:  2017-03-13       Impact factor: 3.133

4.  Effect of α2‑macroglobulin in the early stage of jaw osteoradionecrosis.

Authors:  Jie Li; Ping Yin; Xueying Chen; Xiangbo Kong; Wanzhen Zhong; Yaping Ge; Yangyang She; Xuehong Xian; Lei Qi; Zhi Lin; Justine Moe; Silian Fang
Journal:  Int J Oncol       Date:  2020-04-23       Impact factor: 5.650

5.  Protective effects of α‑2‑macroglobulin on human bone marrow mesenchymal stem cells in radiation injury.

Authors:  Yang Liu; Wanting Cao; Xiangbo Kong; Jie Li; Xueying Chen; Yaping Ge; Wanzhen Zhong; Silian Fang
Journal:  Mol Med Rep       Date:  2018-09-04       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.